Current Perspectives in the Application of Medicinal Plants Against Cancer: Novel Therapeutic Agents
-
Published:2019-05-08
Issue:1
Volume:19
Page:101-111
-
ISSN:1871-5206
-
Container-title:Anti-Cancer Agents in Medicinal Chemistry
-
language:en
-
Short-container-title:ACAMC
Author:
Gezici Sevgi1, Şekeroğlu Nazım2
Affiliation:
1. Department of Molecular Biology and Genetics, Faculty of Science and Literature; Advanced Technology Application and Research Center, Kilis 7 Aralik University, 79000 Kilis, Turkey 2. Department of Food Engineering, Faculty of Engineering and Architecture; Advanced Technology Application and Research Center, Kilis 7 Aralik University, 79000 Kilis, Turkey
Abstract
Background:
Cancer is a disease characterized by uncontrolled cell growth and proliferation. It
has become a major health problem in the past decades and is now the second leading cause of death globally.
Although, there are different types of treatment such as chemotherapy, immune therapy, radiation, hormone
therapy and targeted therapy used against cancer, they have possible side effects and significant deficiencies.
Methods:
This review aims to outline the benefits of medicinal plants and plant-derived products and highlight
why they should be used as novel anti-cancer therapeutics. Electronic databases, including PubMed, Scopus,
ScienceDirect, Cochrane library, and MedlinePlus were searched to summarize in vitro, in vivo and clinical
studies on anticancer effects of medicinal plants and their bioactive compounds up-to-date.
Results:
In recent years, a number of medicinal plants have been administered to cancer patients in order to
prevent and treat cancer as an alternative therapy. These plants were used because of their rich anticarcinogenic
and chemoprotective potentials. In addition to these remarkable properties, these plants have less toxic anticancer,
anti-tumor and anti-proliferation agents than traditional therapeutics. Nevertheless, only a small number
of natural anti-tumor products including vinblastine, vincristine, podophyllotoxin, paclitaxel (Taxol) and camptothecin
have been tested clinically, while vinflunine ditartrate, anhydrovinblastine, NK-611, tafluposide, paclitaxel
poliglumex, combretastatins, salvicine, curcumin, indirubin, triptolide, homoharringtonine are still on trial.
Conclusion:
Consequently, more effective anticancer compounds are identified during the clinical trials; these
natural products could be a key source of antitumor agents in modern anticancer therapy. It is expected that
novel anticancer phytopharmaceuticals produced from medicinal plants could be effectively used in prevention
and therapy for the cancers.
Publisher
Bentham Science Publishers Ltd.
Subject
Cancer Research,Pharmacology,Molecular Medicine
Reference132 articles.
1. Pan L, Chai H, Kinghorn AD. Phytochem Lett, The continuing search for antitumor agents from higher plants. .,, 2010, 3,, 1-8, 2. Song M, Vogelstein B, Giovannucci EL, Willett WC, Tomasetti C. Science, Cancer prevention: Molecular and epidemiologic consensus.,, 2018, 361,, 1317-1318, 3. American cancer society, global cancer facts and figures. American
Cancer Society, Atlanta 2018. Available at, . http://www.cancer.org/ research/cancerfactsstatistics/global, , , 4. Siegel RL, Miller KD, Jemal A. CA Cancer J Clin, Cancer statistics.,, 2018, 68,, 7-30, 5. Balunas MJ, Kinghorn D. Life Sci, Drug discovery from medicinal plants.,, 2005, 78,, 431-441,
Cited by
185 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|